Trials / Completed
CompletedNCT01943721
A Study of the VISION5 Product in Patients With Glaucoma or Ocular Hypertension
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 14 (actual)
- Sponsor
- ForSight Vision5, Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The objective of this Phase 1 study is to evaluate the VISION5 Product's safety and efficacy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | VISION5 Product |
Timeline
- Start date
- 2013-10-01
- Primary completion
- 2014-06-01
- Completion
- 2014-06-01
- First posted
- 2013-09-17
- Last updated
- 2014-12-17
Locations
1 site across 1 country: Latvia
Source: ClinicalTrials.gov record NCT01943721. Inclusion in this directory is not an endorsement.